Inderpal S. Bhandari - 13 Aug 2025 Form 4 Insider Report for Walgreens Boots Alliance, Inc. (WBA)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
15 Aug 2025, 18:08:08 UTC
Prior SEC filing
13 May 2025
Next SEC filing
01 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Inderpal S. Bhandari by Cherita Thomas, Attorney-in-Fact

Key filing fact

Inderpal S. Bhandari filed Form 4 for Walgreens Boots Alliance, Inc. (WBA) on 15 Aug 2025.

Key facts

  • This page summarizes Inderpal S. Bhandari's Form 4 filing for Walgreens Boots Alliance, Inc. (WBA).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 15 Aug 2025, 18:08.

Change

  • Previous filing in this sequence was filed on 13 May 2025.
  • Current net transaction value: +$200,000.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001945907 Primary reporting owner

Bhandari Inderpal S

Relationship
Director
Address
C/O WALGREENS BOOTS ALLIANCE, INC., 108 WILMOT ROAD, DEERFIELD
Signature
/s/ Inderpal S. Bhandari by Cherita Thomas, Attorney-in-Fact
Signature date
15 Aug 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

WBA transaction Derivative

Phantom Stock Units

Award

Transaction value
$200,000
Shares
+16,821
Change %
+51%
Price
$11.89
Shares after
49,779
Date
13 Aug 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
16,821
Exercise price
Footnotes
F1, F2, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The annual phantom stock grant is issued as non-employee director compensation under the Amended and Restated Walgreens Boots Alliance, Inc. 2021 Omnibus Incentive Plan (including the applicable election forms thereunder, the "Plan") in arrears with respect to services rendered over the course of the prior year, and each unit of phantom stock is the economic equivalent of one share of the company's common stock.

Footnote F2

To be settled following termination of service as a director in accordance with the terms and conditions of the Plan.

Footnote F3

Includes phantom stock units that were issued in lieu of dividends on outstanding phantom stock units.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .